Breaking News, Promotions & Moves

Corstasis Therapeutics Appoints Amin Medjamia as VP of Medical Affairs

Medjamia is a physician and medical affairs leader with over 20 years of experience spanning biotechnology and medical devices.

By: Rachel Klemovitch

Assistant Editor

Corstasis Therapeutics, a late clinical-stage innovator of outpatient therapies to treat fluid overload in patients with cardiorenal and hepatic diseases, appointed Amin M. Medjamia M.D. as Vice President of Medical Affairs. At Corstasis, he will oversee clinical strategy, scientific communications, and clinical algorithm development via medical engagement as the company advances its lead program Enbumyst (bumetanide nasal spray). Medjamia is an accomplished physician and medical affairs l...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters